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Our ideas about the management of 
hypertension have changed consider-
ably in recent years. There is now gen-
eral agreement that all patients with 
accelerated hypertension, as mani-
fested by high diastolic pressure and 
Group III and IV funduscopic 
changes, should have their blood pres-
sure reduced with antihypertensive 
agents. Differences of opinion still 
exist, however, in respect to the treat-
ment of the less rapidly advancing 
types of hypertension. It is apparent 
that the life history of untreated es-
sential hypertension varies widely 
from those patients whose lives are 
cut short in a matter of a few years, 
to those who survive to old age. The 
problem is further complicated be-
cause antihypertensive treatment is 
neither simple, innocuous, or inexpen-
sive. 
If we are to approach a solution to 
this problem we need to know the 
answers to two questions. The first is: 
Does antihypertensive treatment pre-
vent the organic complications asso-
ciated with hypertension? and the 
second, How can we recognize and 
differentiate the patient who will de-
velop serious complications from the 
patient who will live out a normal span 
of life? 
Is Therapy of Hypertension Necessary? 
Let us consider first the question of 
blood pressure reduction in prevent-
ing organic complications. The evi-
dence is very good that any form of 
treatment which lowers blood pressure 
has a beneficial effect on hypertensive 
congestive heart failure. Cardiac fail-
ure has fallen from a major cause of 
death to a minor cause in adequately 
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treated hypertensive patients. In addi-
tion, since antihypertensive treatment 
is effective in reversing the accelerated 
phase of hypertension, it follows that 
the transition to the accelerated phase 
should be prevented in adequately 
treated patients. There also is evidence 
that the incidence of cerebral hemor-
rhage has been reduced. Thus, it ap-
pears that antihypertensive therapy is 
useful in preventing congestive heart 
failure, accelerated hypertension, and 
cerebral hemorrhage. 
There are as yet no reliable data 
to indicate whether antihypertensive 
treatment prevents atherosclerotic 
complications such as myocardial in-
farction and cerebral thrombosis. It is 
apparent that hypertension accelerates 
and aggravates the atherosclerotic 
process. Hypertension in some way 
predisposes the arterial walls to the 
deposition of atherosclerotic plaques. 
Atherosclerosis is commonly found in 
the pulmonary artery, for example, in 
long-standing pulmonary hypertension, 
and in the aorta in the region of high 
pressure above a coarctation. Once 
formed , however, it seems highly un-
likely that atherosclerotic plaques 
could be influenced by antihyperten-
sive treatment. In addition, we know 
that chronic elevation of pressure 
leads to structural changes in the ar-
terial walls, including fragmentation 
of elastic tissue. It is possible that 
these irreversible structural changes 
provide a favorable environment for 
the development of atherosclerosis 
even after the blood pressure has been 
reduced. These considerations suggest 
that blood pressure must be lowered 
in the early stages of hypertension if 
antihypertensive treatment is to favor-
ably influence the future course of 
atherosclerotic complications. 
We have similar evidence that hy-
pertension leads to the structural 
changes in the renal arterioles that we 
call nephrosclerosis. The rapidity of 
development, and the severity of the 
nephrosclerotic process, appears to de-
pend on both a persistently high di-
astolic pressure and a susceptible indi-
vidual. In the presence of renovascular 
hypertension, where a stenosis of one 
renal artery is present, producing a 
pressure drop across the narrowed 
segment, nephrosclerosis develops in 
the opposite kidney whose arterioles 
are exposed to the high systemic pres-
sure. In the kidney with the pressure 
drop, whose arterioles are exposed to 
a more normal pressure, nephroscle-
rosis is minimal or nonexistent. If 
nephrosclerosis is to be prevented, this 
again suggests that elevated blood 
pressure must be lowered at a rela-
tively early stage in the disease. 
If there is a relationship between 
elevation of blood pressure and athero-
sclerosis, as well as nephrosclerosis, 
then it is reasonable to assume that the 
extent of these pathological changes 
will depend on both the height and 
the duration of the blood pressure. If 
the blood pressure is high for only 
brief periods of time, and is normal 
at all other times, we would not expect 
to find vascular pathology. However, 
if the pressure is high all of the time, 
both day and night, and if this per-
sistently high pressure lasts for many 
months or years, then vascular pa-
thology would be expected. 
Variability of Blood Pressure Readings 
Blood pressure represents a variable 
manifestation. It can be strongly in-
fluenced by emotion, particularly by 
fear and apprehension. There are some 
individuals who from childhood mani-
fest transient elevations of blood pres-
sure, associated with apprehension, 
who never develop a persistent eleva-
tion of blood pressure throughout a 
normal life span. These individuals 
may, ii;i middle and older age, exhibit 
pressures of 230/ 130 or even higher 
during a visit to a doctor's office or a 
clinic, and yet at home their blood 
pressure will be -normal. Such hyper-
responsiveness may develop in middle 
age, particularly in females, or in old 
age in both sexes, as was shown by 
Pickering almost 30 years ago. These 
individuals may show very little or-
ganic progression. 
Other hypertensive patients exhibit 
elevation of blood pressure throughout 
the day, whether they are at home or 
hospitalized. These patients will almost 
all exhibit organic changes, - and the 
rate of progression varies in general 
with the height of the diastolic blood 
pressure. 
Predicting the Prognosis of Hyperten-
sion and Need for Therapy 
Thus, in evaluating hypertensive pa-
tients for treatment, we should con-
sider not only the height of the blood 
pressure but, more important, its per-
sistence or duration. When we meas-
ure blood pressure only in the office or 
clinic we should realize that we are 
being presented with a mixture of 
populations, some of which have se-
vere pressure elevations most of the 
time, some with considerably less hy-
pertension than they exhibit in the 
office most of the time, and some which 
are not hypertensive at all but hyper-
react to situations associated with ap-
prehension. 
Another way of estimating prog-
nosis is to determine whether organic 
changes are already present. We 
should utilize the history, the fundu-
scopic examination, the electrocardio-
gram, chest x-ray, and renal function 
tests to estimate the degree of such 
damage. Unfortunately, these changes 
do not become apparent by ordinary 
clinical tests until structural damage is 
already well advanced. As pointed out 
previously, if antihypertensive treat-
ment can -be expected to produce a 
beneficial effect in preventing nephro-
sclerosis and accelerated atheroscle-
rosis, it should be given in an early 
stage of the disease. 
It seems evident, therefore, that 
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physicians should obtain · a more ac-
c~rate estimate of the average blood 
pressure than has been customary in 
the past. If the office blood pressure is 
not a reliable guide, then we should 
determine what the blood pressure is 
under more representative circum-
stances. The most representative blood 
pressure that is practicably obtainable 
is that recorded in the home, not by 
the physician but by the patient him-
self, or better yet, · by a member of his 
family. The office nurse can easily and 
quickly teach such individuals how to 
record blood pressure, and a few ma-
nometers can be kept on hand for two-
week loans. The pressure should be 
recorded morning and evening for two 
weeks in the home and the record 
brought to the office on the next 
scheduled visit. Frequently, the blood 
pressure readings drop immediately or 
ov~r a period of days to normotensive 
levels. However, the finding of a per-
sistent diastolic elevation above 90 
mm of Hg is an important criterion for 
instituting antihypertensive treatment. 
The higher the elevation, the more in-
tensive the treatment will be. Of 
course, it is important to make certain 
that the blood pressure is being taken 
accurately by having the individual 
record the pressure in the physician's 
presence at the time of the office visit. 
Other useful prognostic indices, be-
sides the estimate of the average blood 
pressure and the survey for organic 
damage, are the age, sex, and race of 
the patient, and the rate of progres-
sion. These factors are well known 
and require no emphasis. 
Antihypertensive Drugs 
Saluretic Agents (Thiazides); Reserpine 
and Hydralazine 
In the patient with persistently ele-
vated diastolic blood pressure, but 
with little or no signs of organic dam-
age, treatment can begin with an oral 
saluretic agent. This generally is not 
sufficient by itself to reduce the dias-
tolic pressure to normal. If it is not, 
0.5 mg of reserpine twice daily for two 
weeks, followed by a maintenance 
dose of 0.25 mg once daily can be 
added; or else hydralazine (Apreso-
line) may be added in a dose of 25 mg 
two to three times daily. If the latter 
is not effective, the dose can be in-
creased gradually to 50 mg three times 
daily. 
Saluretic agents plus reserpine fre-
quently provide an effective combina-
tion therapy in uncomplicated hyper-
tension. The regimen also is convenient 
because long-acting diuretics can be 
combined with 0.25 mg of reserpine, to 
be taken only once daily. 
The principal toxic effect of reser-
pine is mental depression. Generally, 
the more intelligent the patient, the 
greater the danger of reserpine-in-
duced depression. Unfortunately, other 
alkaloids of Rauwolfia are not very 
effective as antihypertensive agents 
and, therefore, cannot be substituted. 
It is important when prescribing reser-
pine to tell the patient that if he 
should begin to feel unaccountably 
depressed or to develop sleep disturb-
ances, such as early morning awaken-
ing, he should immediately discontinue 
the drug. In addition, one should 
strive for the lowest possible main-
tenance dose, which lies between 0.1 
mg and 0.25 mg daily in different pa-
tients. 
The serious toxicity associated with 
hydralazine is definitely dose depend-
ent. The chief toxic reaction consists 
of a syndrome resembling dissemi-
nated lupus which rarely, if ever, oc-
curs when the total daily dose is main-
tained at 150 mg or less per day. The 
acute side effects of hydralazine can 
be avoided by a few simple maneuvers. 
The first is to add hydralazine to the 
regimen of a patient already being 
treated with a diuretic or reserpine or 
both. The latter two drugs, and par-
ticularly reserpine, tend to combat or 
neutralize the acute hydralazine side 
effects which are headache, palpita-
tion, and tachycardia. The second ma-
neuver is to institute the drug in low 
and widely spaced doses, increasing 
gradually. For example, hydralazine 
can be started in a dose of 25 mg once 
daily, increasing in two or three days 
to twice daily, and after a similar in-
terval to three times daily. It is sur-
prising how frequently a small dose of 
25 mg two or three times daily is ef-
fective in uncomplicated hypertension 
when it is added to the diuretics with 
reserpine, or to reserpine alone. The 
trial of hydralazine, however, should 
not be abandoned until the dose has 
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been increased to 50 mg three times 
daily. 
Drugs in combination 
The results of the large scale double-
blind V.A. Cooperative Study on Anti-
hypertensive Agents clearly showed 
the additive effects of these three drugs 
in producing a reduction of blood 
pressure. The combinations of reser-
pine and thiazides, or of hydralazine-
reserpine, or hydralazine-thiazide were 
clearly more effective in reducing 
blood pressure than any of these 
agents used alone. The combination of 
all three agents was most effective, re-
ducing the average diastolic blood 
pressure to below 90 mm in the pa-
tients that had been classified as hav-
ing hypertension of mild and moderate 
severity. 
In patients whose blood pressures 
are not controlled with any of these 
combinations of diuretic-reserpine and 
hydralazine, it is advisable first of all 
to make certain that you are not being 
misled by high office recordings. Pa-
tients whose blood pressures are well 
controlled at home may completely 
overcome the antihypertensive effects 
of the drugs in the office or clinic. 
Here again a record of home blood 
pressures, taken over a two week pe-
riod, will go far to clarify the situa-
tion. 
Since the saluretic agents are used so 
widely in the treatment of hyperten-
sion, it is important to consider their 
adverse reactions. The most common 
disturbance produced by thiazides is 
a reduction in serum potassium levels. 
This usually causes no difficulty unless 
the patient is receiving digitalis alka-
loids, in which case arrhythmias fre-
quently are induced, due to the in-
creased activity of digitalis in the 
presence of a reduction in extracellu-
lar potassium concentration. Although 
it is customary to advise ingestion of 
excess potassium in this circumstance, 
this cannot be depended upon to raise 
the serum potassium level. 
Another frequent side effect of thia-
zide administration is hyperuricemia 
due to inhibition of renal tubular se-
cretion of uric acid. In azotemic pa-
tients, this frequently precipitates at-
tacks of gout.. It seldom does in 
non-azotemic patients. It is advisable 
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to control the blood pressure without 
thiazides in patients who develop gout. 
However, at times the situation de-
mands thiazide treatment. In such a 
case probenecid is given to combat the 
hyperuricemia and colchicine is ad-
ministered when necessary to control 
symptoms. 
Patients with severe renal damage 
and acidosis often are unable to con-
serve salt. If they are placed on salt 
restricted diets, and at the same time 
are given thiazides, nitrogen retention 
may be intensified. The administra-
tion of sodium bicarbonate or sodium 
lactate to such patients sometimes re-
sults in diuresis with a fall in BUN 
and in the degree of acidosis. 
Diabetes mellitus is occasionally pre-
cipitated by thiazides. The incidence 
of this complication is low and it is 
difficult always to distinguish between 
spontaneous diabetes and the drug 
induced variety. Finally, thiazides may 
induce hypersensitivity reactions with 
skin rash and, on rare occasions, throm-
bocytopenic purpura. 
Adrenergic Blocking Agents 
If the response to a combination of 
diuretic plus low doses of reserpine 
and hydralazine truly does not control 
the blood pressure, the physician has 
the choice of using diuretics plus 
adrenergic blocking agents, such as 
methyldopa (Aldomet), guanethidine 
(Ismelin), or pargyline (Eutonyl). 
Orthostatic hypotension poses the 
main problem in administering the ad-
renergic blocking agents. The physician 
should be prepared to deal with this 
side effect if he is to effectively treat 
patients with severe hypertension. The 
important points in managing patients 
undergoing treatment with the block-
ing drugs are these: 
1) Use saluretic agents in conjunc-
tion with blocking drugs whenever 
possible. The former tend to smooth 
out the large diurnal fluctuations of 
blood pressure induced by the block-
ing agents, and to maintain a more 
constant antihypertensive response 
from one day to the next. Saluretic 
agents also increase the responsiveness 
of the blocking agents, permitting 
lower doses of the latter. 
2) Tell the patient at the time treat-
ment is begun that the drug lowers 
the blood pressure in the erect posi-
tion, that it may reduce it to such a 
point that he feels faint, but that the 
dose can be adjusted so that this 
symptom will not be troublesome. 
3) Tell the patient that, if he does 
develop weakness or faintness, he is to 
discontinue all antihypertensive medi-
cations for that day and remain in 
bed until the faintness disappears. If 
the faintness has disappeared by the 
next day, he is to begin again at a 
slightly lower dose of the blocking 
agent, specifically a decrease of 10 to 
20% . If the dose is drastically re-
duced, the antihypertensive effect will 
disappear. The aim, therefore, is to 
find the maximum tolerable dose, and 
this is frequently just below the one 
which produces symptoms of ortho-
static hypotension. 
4) Tell the patient to be cautious 
about drinking alcohol, as the latter 
in conjunction with blocking drugs 
may induce symptomatic hypotension. 
Strenuous exercise also may precipi-
tate orthostatic hypotension. 
5) Doses are titrated up to the 
effective level. The initial dose is small, 
but it is increased gradually until an 
antihypertensive effect or symptoms of 
orthostatic hypotension occur. 
6) Reassure the patient that if ortho-
static faintness or syncope occurs, it 
is not as serious as it seems; that it is 
equivalent to an ordinary faint, and 
that it can be avoided by proper regu-
lation of dosage. 
7) If the patient complains of ortho-
static faintness, particularly in the 
morning, and if the office blood pres-
sures are still elevated without a fall 
on standing, it may be either that the 
orthostatic effect disappears in the 
afternoon or evening, or else that the 
office recordings are abnormally ele-
vated due to apprehension. If possible, 
the patient should visit the office in 
the morning when pressures are usu-
ally the lowest. Best of all is to have 
twice daily recordings taken in the 
home by a member of the family or 
the patient himself. Home blood pres-
sure recordings are an invaluable ad-
junct in the treatment of severe hyper-
tensive patients whose blood pressure 
levels are difficult to control. 
Relative Merits of Methyldopa, Guan-
ethidine, and Pargyline 
Methyldopa is well tolerated be-
cause it produces less severe ortho-
static hypotension and does not usu-
ally interfere with sexual function. It 
also depresses renal function less than 
guanethidine in patients with renal 
failure. On the other hand, it is effec-
tive in controlling blood pressure in 
only about half ot the patients with 
severe hypertension. Three to four 
doses per day are required as com-
pared to only one dose per day of the 
other blocking agents; it occasionally 
produces fever and hepatitis, and it is 
more expensive than the other drugs. 
Methyldopa is begun in a dose of 250 
mg three times daily, increasing as 
necessary to a level of 750 mg four 
times daily. Elevations beyond this 
level generally produce little additional 
antihypertensive effect. The most fre-
~uent side effect is drowsiness, which 
1s usually transient, tending to disap-
pear after a stable dose level has 
been maintained for several weeks. 
. Guanethidine or Ismelin is begun 
~n a dose of 10 mg once daily, and is 
mcreased every week by 10 mg until 
orthostatic hypotension or a reduction 
in supine pressure appears. In hos-
pitalized patients or in those with se-
vere hypertension, the doses can be 
raised more rapidly. The maximum 
dose is about 200 mg daily, although 
most patients will exhibit an antihyper-
tensive effect in the range of 25 to 75 
mg when thiazides are given adjunc-
tively. 
Guanethidine probably lowers blood 
~ressure .in a greater percentage of pa-
tients with severe hypertension than 
does any other drug. Dosage also is 
co~venient since the total daily re-
qm~eme~t can be taken once daily in 
coniunction with a long-acting saluretic 
agent. No hypersensitivity reactions 
or serious organ toxicity have been ob-
served. Because it is a potent blocking 
agent, it is capable of inducing pro-
found orthostatic hypotension. Once 
the dose is regulated, however, patients 
generally are not disturbed by this side 
effect. Diarrhea may be troublesome 
and usually calls for a slight reduction 
in dose. Atropine-like compounds, as 
well as paregoric, also can be used to 
combat this side reaction. While under 
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the influence of adrenergic blockade 
impotence occurs because orgasm i~ 
associated with ejaculation into the 
urinary bladder. 
Another blocking agent in current 
use is pargyline or Eutonyl. Effective 
doses vary widely from as little as 10 
mg to as much as 100 mg per day. If 
the latter dose is ineffective, larger 
amounts generally will not be effective. 
Pargyline is a monamine oxidase in-
hibitor and "psychic energizer." It 
does produce increased alertness and 
drive, sometimes to the point of induc-
ing insomnia. Severe orthostatic hypo-
tension can occur even in low doses. 
The onset of this latter effect may be 
delayed for several weeks or longer. 
For this reason, the doses should be 
gradually elevated with increases at 
widely spaced intervals several weeks 
apart. 
Patients taking monamine oxidase 
inhibitors may develop severe and even 
fatal hypertensive responses following 
the ingestion of processed cheese. This 
unusual side effect is thought to be 
due to tyramine which is present in 
cheese. 
It can be seen from this brief re-
view that all antihypertensive agents 
are potentially toxic. The decision to 
treat a given patient, therefore, should 
not be undertaken lightly. To the risk 
of toxicity must be added the incon-
venience and expense involved in life-
long treatment. An assessment of the 
average blood pressure and the extent 
of organic damage already present will 
help in separating those patients who 
require no treatment, and in determin-
ing in the remainder how intensive the 
therapeutic program need be. The 
deat~ rates from hypertension, hyper-
tensive heart disease, and cerebral 
hemorrhage appear to have been strik-
ingly reduced since the advent of anti-
hypertensive drug treatment. There-
fore, this note of caution is not meant 
to discourage the application of anti-
hypertensive agents, but rather to ad-
vocate care and discrimination in their 
use. 
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